Procter & Gamble (P&G) reported a mixed performance for Q1 FY 2025, with net sales decreasing by 1% to $21.7 billion, while organic sales grew by 2% from the previous year’s base period, which had shown 7% growth. The diluted earnings per share (EPS) declined by 12% to $1.61, influenced by restructuring costs, but core […]
Procter & Gamble has issued a voluntary recall of one stock-keeping unit (SKU) of Zevo Fly, Gnat and Fruit Fly Flying Insect Killer Value Packs in the US owing to a potential packaging issue. According to the consumer goods company, the recall is for lot code 3045D185EW3 that was dispatched on or after 13 March […]
In a significant boost to its consumer health portfolio, Procter & Gamble (P&G) has concluded its €3.4 billion acquisition of German pharmaceutical giant Merck’s consumer health business. This move, first announced in April 2018, aims to elevate P&G’s position in the global over-the-counter (OTC) health market, adding extensive geographical scale and expanding its presence across […]
Procter & Gamble (P&G), a leading US consumer goods company, has finalized a deal to acquire the consumer health business of German pharmaceutical company Merck for approximately €3.4 billion ($4.2 billion). This all-cash transaction marks a significant expansion of P&G’s consumer health division by incorporating a range of over-the-counter (OTC) products from Merck. Expanding P&G’s […]